Polymeric growth factor delivery strategies for tissue engineering

被引:290
作者
Chen, RR
Mooney, DJ [1 ]
机构
[1] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA
基金
美国国家卫生研究院;
关键词
regeneration; drug delivery; gene delivery; cell transplantation;
D O I
10.1023/A:1025034925152
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. Tissue engineering seeks to replace and regrow damaged or diseased tissues and organs from either cells resident in the surrounding tissue or cells transplanted to the tissue site. The purpose of this review is to present the application of polymeric delivery systems for growth factor delivery in tissue engineering. Methods. Growth factors direct the phenotype of both differentiated and stem cells, and methods used to deliver these molecules include the development of systems to deliver the protein itself, genes encoding the factor, or cells secreting the factor. Results. Results in animal models and clinical trials indicate that these approaches may be successfully used to promote the regeneration of numerous tissue types. Conclusions. Controlling the dose, location, and duration of these factors through polymeric delivery strategies will dictate their utility in tissue regeneration.
引用
收藏
页码:1103 / 1112
页数:10
相关论文
共 82 条
  • [1] Recombinant proteins for neurodegenerative diseases: the delivery issue
    Aebischer, P
    Ridet, JL
    [J]. TRENDS IN NEUROSCIENCES, 2001, 24 (09) : 533 - 540
  • [2] Engineering growing tissues
    Alsberg, E
    Anderson, KW
    Albeiruti, A
    Rowley, JA
    Mooney, DJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (19) : 12025 - 12030
  • [3] Andrades J A, 1996, Int J Dev Biol, VSuppl 1, p107S
  • [4] Effect of controlled release of platelet-derived growth factor from a porous hydroxyapatite implant on bone ingrowth
    Arm, DM
    Tencer, AF
    Bain, SD
    Celino, D
    [J]. BIOMATERIALS, 1996, 17 (07) : 703 - 709
  • [5] In vivo characteristics of cationic liposomes as delivery vectors for gene therapy
    Audouy, SAL
    de Leij, LFMH
    Hoekstra, D
    Molema, G
    [J]. PHARMACEUTICAL RESEARCH, 2002, 19 (11) : 1599 - 1605
  • [6] Experimental studies on bone induction using low-molecular-weight poly (DL-lactide-co-glycolide) as a carrier for recombinant human bone morphogenetic protein-2
    Bessho, K
    Carnes, DL
    Cavin, R
    Ong, JL
    [J]. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 2002, 61 (01): : 61 - 65
  • [7] Successful transpedicular lumbar interbody fusion by means of a composite of osteogenic protein-1 (rhBMP-7) and hydroxyapatite carrier - A comparison with autograft and hydroxyapatite in the sheep spine
    Blattert, TR
    Delling, G
    Dalal, PS
    Toth, CA
    Balling, H
    Weckbach, A
    [J]. SPINE, 2002, 27 (23) : 2697 - 2705
  • [8] Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans - A prospective, randomized clinical pilot trial - 2002 Volvo Award in clinical studies
    Boden, SD
    Kang, J
    Sandhu, H
    Heller, JG
    [J]. SPINE, 2002, 27 (23) : 2662 - 2673
  • [9] BOWENPOPE DF, 1984, BLOOD, V64, P458
  • [10] Cultured skin substitutes reduce donor skin harvesting for closure of excised, full-thickness burns
    Boyce, ST
    Kagan, RJ
    Yakuboff, KP
    Meyer, NA
    Rieman, MT
    Greenhalgh, DG
    Warden, GD
    [J]. ANNALS OF SURGERY, 2002, 235 (02) : 269 - 279